← Back to contracts

Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)

US National Institutes of Health (NIH) grant open #PAR-25-255
Response due Nov 05, 2026 · 00:00 UTC

Summary

This NIH R01 funding opportunity (PAR-25-255) invites applications to develop novel theory and computational/statistical methods for understanding the genetic architecture of complex human traits. Clinical trials are explicitly excluded from this mechanism. The opportunity is posted through Grants.gov under the HHS-NIH umbrella and remains open for roughly two years, suggesting multiple submission cycles. Applicants are expected to pursue foundational and/or methodological research rather than clinical intervention studies.

What they want

Technical requirements
  • Novel theory and/or methods development targeting genetic architecture of complex human traits
  • Clinical trials not allowed under this funding mechanism
  • Must conform to NIH R01 application requirements

How they evaluate

Submission: Grants.gov electronic submission portal

Risks & flags

  • No dollar figures or budget caps stated — award value entirely unknown from this notice
  • Long open window (2 years) likely implies multiple standard NIH receipt date cycles, but this is not confirmed in the text
  • Highly specialized scope (novel theory and methods for genetic architecture) may limit competitive field to a small number of research groups

Market context

inferred from NAICS
R&D in Physical, Engineering, Life Sciences (except Nanotech & Biotech)
NAICS 541715
US market size
$95B
Typical award
$100K – $50M+
Typical buyers
DoDNSFNIHNASADOE
Commonly required
DCAA-compliant accountingITARCMMC L2
Developing novel theory and methods for un…
Due Nov 05
Onboard